{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T13:47:03Z","timestamp":1792072023567,"version":"4.4.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["M\u00e9decine et Maladies Infectieuses"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.medmal.2017.09.001","type":"journal-article","created":{"date-parts":[[2017,10,12]],"date-time":"2017-10-12T18:32:20Z","timestamp":1507833140000},"page":"53-57","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Tigecycline-based prolonged salvage therapy in patients presenting with complex bone and joint infection"],"prefix":"10.1016","volume":"48","author":[{"given":"J.","family":"Wach","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Dinh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Dutronc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.R.","family":"Sipahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Candevir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Valour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Zeller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Lustig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Laurent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Chidiac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Ferry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.medmal.2017.09.001_bib0105","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1517\/17425255.2011.623126","article-title":"Pharmacokinetic and pharmacodynamic evaluation of tigecycline","volume":"7","author":"Giamarellou","year":"2011","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.medmal.2017.09.001_bib0110","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/S1473-3099(11)70177-3","article-title":"Efficacy and safety of tigecycline for the treatment of infectious diseases: a meta-analysis","volume":"11","author":"Tasina","year":"2011","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.medmal.2017.09.001_bib0115","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1093\/jac\/dkr242","article-title":"Efficacy and safety of tigecycline: a systematic review and meta-analysis","volume":"66","author":"Yahav","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.medmal.2017.09.001_bib0120","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1093\/cid\/cis270","article-title":"Excess deaths associated with tigecycline after approval based on noninferiority trials","volume":"54","author":"Prasad","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.medmal.2017.09.001_bib0125","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1093\/jac\/dki109","article-title":"Comparative evaluation of tigecycline and vancomycin, with and without rifampicin, in the treatment of methicillin-resistant Staphylococcus aureus experimental osteomyelitis in a rabbit model","volume":"55","author":"Yin","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.medmal.2017.09.001_bib0130","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1179\/joc.2008.20.1.53","article-title":"Comparison of the efficacy of tigecycline and teicoplanin in an experimental methicillin-resistant Staphylococcus aureus osteomyelitis model","volume":"20","author":"Kandemir","year":"2008","journal-title":"J Chemother Florence Italy"},{"key":"10.1016\/j.medmal.2017.09.001_bib0135","doi-asserted-by":"crossref","first-page":"512","DOI":"10.3201\/eid1403.070128","article-title":"Multidrug-resistant Acinetobacter baumannii osteomyelitis from Iraq","volume":"14","author":"Schafer","year":"2008","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.medmal.2017.09.001_bib0140","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.diagmicrobio.2010.06.009","article-title":"Salvage therapy with tigecycline for recurrent infection caused by ertapenem-resistant extended-spectrum \u03b2-lactamase-producing Klebsiella pneumoniae","volume":"68","author":"Chen","year":"2010","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.medmal.2017.09.001_bib0145","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/IPC.0b013e3182183339","article-title":"Diabetic foot osteomyelitis due to Klebsiella pneumoniae carbapenemase-producing Klebsiella pneumoniae","volume":"19","author":"Tascini","year":"2011","journal-title":"Infect Dis Clin Pract"},{"key":"10.1016\/j.medmal.2017.09.001_bib0150","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1099\/jmm.0.47286-0","article-title":"Successful treatment of multi-resistant Pseudomonas aeruginosa osteomyelitis after allogeneic bone marrow transplantation with a combination of colistin and tigecycline","volume":"56","author":"Stanzani","year":"2007","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.medmal.2017.09.001_bib0155","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/IPC.0b013e31802df51b","article-title":"Successful treatment of Mycobacterium fortuitum osteomyelitis after allogeneic bone marrow transplantation","volume":"15","author":"Rolfe","year":"2007","journal-title":"Infect Dis Clin Pract"},{"key":"10.1016\/j.medmal.2017.09.001_bib0160","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/IPC.0b013e3181d04a09","article-title":"Successful tigecycline combination therapy for Mycobacterium abscessus infection of a total hip arthroplasty","volume":"18","author":"Yinkey","year":"2010","journal-title":"Infect Dis Clin Pract"},{"key":"10.1016\/j.medmal.2017.09.001_bib0165","doi-asserted-by":"crossref","first-page":"3096","DOI":"10.1128\/JCM.00603-11","article-title":"Prosthetic joint infection caused by Mycobacterium alvei in an elderly patient","volume":"49","author":"Lee","year":"2011","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.medmal.2017.09.001_bib0170","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jbspin.2011.05.025","article-title":"Tigecycline option for the treatment of bone and joint infections caused by multidrug-resistant Staphylococcus epidermidis","volume":"79","author":"Asseray","year":"2012","journal-title":"Jt Bone Spine Rev Rhum"},{"key":"10.1016\/j.medmal.2017.09.001_bib0175","first-page":"18","article-title":"Tigecycline in the management of post-neurosurgical spondylodiscitis: a review of eight cases","author":"Sipahi","year":"2014","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.medmal.2017.09.001_bib0180","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.diagmicrobio.2013.07.014","article-title":"Tigecycline in the management of osteomyelitis: a case series from the bone and joint infection (BAJIO) database","volume":"77","author":"Griffin","year":"2013","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.medmal.2017.09.001_bib0185","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.diagmicrobio.2013.12.007","article-title":"Phase 3 study comparing tigecycline and ertapenem in patients with diabetic foot infections with and without osteomyelitis","volume":"78","author":"Lauf","year":"2014","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.medmal.2017.09.001_bib0190","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1093\/jac\/dku062","article-title":"Clinical experience in 52 patients with tigecycline-containing regimens for salvage treatment of Mycobacterium abscessus and Mycobacterium chelonae infections","volume":"69","author":"Wallace","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.medmal.2017.09.001_bib0195","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/phar.1159","article-title":"Tigecycline-related pancreatitis: a review of spontaneous adverse event reports","volume":"33","author":"Okon","year":"2013","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.medmal.2017.09.001_bib0200","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1007\/s00277-010-0911-7","article-title":"Severe coagulation disorder with hypofibrinogenemia associated with the use of tigecycline","volume":"89","author":"Pieringer","year":"2010","journal-title":"Ann Hematol"}],"container-title":["M\u00e9decine et Maladies Infectieuses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0399077X16306618?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0399077X16306618?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T01:16:05Z","timestamp":1759972565000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0399077X16306618"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["S0399077X16306618"],"URL":"https:\/\/doi.org\/10.1016\/j.medmal.2017.09.001","relation":{},"ISSN":["0399-077X"],"issn-type":[{"value":"0399-077X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tigecycline-based prolonged salvage therapy in patients presenting with complex bone and joint infection","name":"articletitle","label":"Article Title"},{"value":"M\u00e9decine et Maladies Infectieuses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medmal.2017.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}